Triangle Securities Wealth Management
- SEC CIK
- 0001541353
- Latest filing
- Jul 14, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Triangle Securities Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,709
- Value
- $848.9K
- % of portfolio
- 0.2%
- Quarters held
- 21
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,709 | $848.9K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,709 | $763.1K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,709 | $774.8K | 0.2% | −27−1.6% | Reduced | Holders |
| Q3 2025 | 1,736 | $679.9K | 0.2% | +8+0.5% | Added | Holders |
| Q2 2025 | 1,728 | $769.3K | 0.2% | +10+0.6% | Added | Holders |
| Q1 2025 | 1,718 | $832.9K | 0.2% | −48−2.7% | Reduced | Holders |
| Q4 2024 | 1,766 | $711.2K | 0.2% | −19−1.1% | Reduced | Holders |
| Q3 2024 | 1,785 | $830.2K | 0.2% | −45−2.5% | Reduced | Holders |
| Q2 2024 | 1,830 | $857.8K | 0.2% | −20−1.1% | Reduced | Holders |
| Q1 2024 | 1,850 | $773.3K | 0.2% | −43−2.3% | Reduced | Holders |
| Q4 2023 | 1,893 | $770.2K | 0.2% | −98−4.9% | Reduced | Holders |
| Q3 2023 | 1,991 | $692.4K | 0.2% | −159−7.4% | Reduced | Holders |
| Q2 2023 | 2,150 | $756.6K | 0.3% | −200−8.5% | Reduced | Holders |
| Q1 2023 | 2,350 | $740.4K | 0.3% | −58−2.4% | Reduced | Holders |
| Q4 2022 | 2,408 | $695.4K | 0.3% | −450−15.7% | Reduced | Holders |
| Q3 2022 | 2,858 | $828.0K | 0.3% | −205−6.7% | Reduced | Holders |
| Q2 2022 | 3,063 | $863.0K | 0.3% | +173+6.0% | Added | Holders |
| Q1 2022 | 2,890 | $754.0K | 0.3% | −258−8.2% | Reduced | Holders |
| Q4 2021 | 3,148 | $691.0K | 0.2% | +135+4.5% | Added | Holders |
| Q3 2021 | 3,013 | $547.0K | 0.2% | +425+16.4% | Added | Holders |
| Q2 2021 | 2,588 | $522.0K | 0.2% | +2,588 | New | Holders |